Serum Reg-Iα is not suitable marker of metabolic syndrome

被引:0
|
作者
Stejskal, D. [1 ]
Karpisek, M. [2 ]
Horakova, D. [3 ]
Cizek, L. [3 ]
Janoutova, G. [3 ]
Janout, V [3 ]
机构
[1] Sternberk Hosp, Outpatient Ctr, Dept Lab Med & Metab & Diabet, CZ-78516 Sternberk, Czech Republic
[2] Vet &Pharmacol Fac Brno, Brno, Czech Republic
[3] Palacky Univ Olomouc, Inst Prevent Med, Olomouc, Czech Republic
关键词
serum Reg-I alpha; metabolic syndrome; tissue regeneration;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Reg-1 alpha plays a role in various types of tissue regeneration. Aim: To evaluate serum Reg-1 alpha for the diagnosis of metabolic syndrome. Methods: 14 non-obese, healthy subjects and 15 individuals with metabolic syndrome were studied. Anthropometric and laboratory analysis in sera (Body Mass Index - BMI, insulin, triglycerides, cholesterol, HDL-cholesterol, LDL-cholesterol, uric acid, aglucose, Quicki calculation, Reg-1 alpha) were performed. Results: Reg-1 alpha levels did not differ between subjects with metabolic syndrome and healthy subjects (means 597.7 vs 631.1 ng/l, p<0.01) and positively correlated only with fasting glucose (r=0.34; p<0.01) and age (r=0.38; p<0.01); Reg-1 alpha correlated even after adjustment to age. Reg-1 alpha concentrations did not differ in men and women. Conclusions: Our study, for the first time, indicates that serum Reg-1 alpha is not useful for the diagnosis of metabolic syndrome.
引用
收藏
页码:138 / 140
页数:3
相关论文
共 50 条
  • [31] Serum galectin-3BP as a novel marker of obesity and metabolic syndrome in Chinese adolescents
    Zhen, Shihan
    Ma, Yanan
    Han, Yanshuo
    Zhao, Zhongyi
    Yang, Xuelian
    Wen, Deliang
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [32] Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?
    Jarecki, Piotr
    Herman, Waldemar A.
    Pawliczak, Elzbieta
    Lacka, Katarzyna
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2181 - 2191
  • [33] Serum REG Iα as a potential novel biomarker in cancer An observational study
    Zhang, Yumin
    Yuan, Xuelu
    Zhu, Xiangyun
    Wang, Qian
    Yu, Xuebing
    Wei, Qiong
    Li, Ling
    MEDICINE, 2020, 99 (38) : E22281
  • [34] Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan
    Yokokawa, Hirohide
    Goto, Aya
    Terui, Kazushi
    Funami, Yoshinari
    Watanabe, Kazuo
    Yasumura, Seiji
    JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (07) : 769 - 773
  • [35] Serum adipokines and metabolic syndrome
    Olszanecka-Glinianowicz, M.
    Zahorska-Markiewicz, B.
    Janowska, J.
    Kocelak, P.
    Semik-Grabarczyk, E.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S163 - S163
  • [36] Association of Serum PSP/REG I with Renal Function in Pregnant Women
    Zhu, Xiangyun
    Dong, Beibei
    Reding, Theresia
    Peng, Youfan
    Lin, Hao
    Zhi, Mengmeng
    Han, Manman
    Graf, Rolf
    Li, Ling
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [37] Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker
    Hayashi, Tetsutaro
    Matsubara, Akio
    Ohara, Shinya
    Mita, Koji
    Hasegawa, Yasuhisa
    Usui, Tsuguru
    Arihiro, Koji
    Norimura, Shinichi
    Sentani, Kazuhiro
    Oue, Naohide
    Yasui, Wataru
    ONCOLOGY REPORTS, 2009, 21 (01) : 95 - 100
  • [38] Is serum cystatin-C a suitable marker of renal function in children?
    Zaffanello, Marco
    Franchini, Massimo
    Fanos, Vassilios
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2007, 37 (03): : 233 - 240
  • [39] Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
    Liu, Tianhui
    Yao, Mingjie
    Liu, Shuhong
    Wang, Lu
    Wang, Leijie
    Hou, Jinlin
    Ma, Xiong
    Jia, Jidong
    Zhao, Jingmin
    Zhuang, Hui
    Lu, Fengmin
    ONCOTARGET, 2017, 8 (10) : 16498 - 16506
  • [40] Red Iα and Reg IV As a Mucin Phenotype and/or a Prognostic Marker in Advanced Gastric Cancer
    Yamagishi, Hidetsugu
    Fukui, Hirokazu
    Sekikawa, Akira
    Ogata, Hideo
    Fujii, Shigehiko
    Ichikawa, Kazuhito
    Tomita, Shigeki
    Imura, Johji
    Fujimori, Takahiro
    GASTROENTEROLOGY, 2009, 136 (05) : A758 - A758